Atomic layering thermostable antigen and adjuvant (ALTA®) provides unique, controlled antigen release to improve immune response to vaccination.
Saved in:
| Title: | Atomic layering thermostable antigen and adjuvant (ALTA®) provides unique, controlled antigen release to improve immune response to vaccination. |
|---|---|
| Authors: | Strand KA; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., D'Angelo H; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Olson AM; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Walters IR; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Snyder EM; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Ritter AM; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Hite E; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Wijesundara YH; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Caplan AB; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Ivanova DL; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Allen I; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Han Y; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Antunez LR; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Dey AK; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Steadman BL; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA., Brubaker SW; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA. Electronic address: sbrubaker@vitrivaxbio.com. |
| Source: | Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2026 Jul 10; Vol. 395, pp. 114984. Date of Electronic Publication: 2026 May 04. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42092615 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Atomic layering thermostable antigen and adjuvant (ALTA®) provides unique, controlled antigen release to improve immune response to vaccination. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Strand+KA%22">Strand KA</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22D'Angelo+H%22">D'Angelo H</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Olson+AM%22">Olson AM</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Walters+IR%22">Walters IR</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Snyder+EM%22">Snyder EM</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Ritter+AM%22">Ritter AM</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Hite+E%22">Hite E</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Wijesundara+YH%22">Wijesundara YH</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Caplan+AB%22">Caplan AB</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Ivanova+DL%22">Ivanova DL</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Allen+I%22">Allen I</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Han+Y%22">Han Y</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Antunez+LR%22">Antunez LR</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Dey+AK%22">Dey AK</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Steadman+BL%22">Steadman BL</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA.<br /><searchLink fieldCode="AU" term="%22Brubaker+SW%22">Brubaker SW</searchLink>; VitriVax, Inc., 5500 Central Avenue, Boulder, CO 80301, USA. Electronic address: sbrubaker@vitrivaxbio.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228607908%22">Journal of controlled release : official journal of the Controlled Release Society</searchLink> [J Control Release] 2026 Jul 10; Vol. 395, pp. 114984. <i>Date of Electronic Publication: </i>2026 May 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8607908 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201683659%22">01683659 </searchLink><i>NLM ISO Abbreviation: </i>J Control Release <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42092615 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jconrel.2026.114984 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 114984 Titles: – TitleFull: Atomic layering thermostable antigen and adjuvant (ALTA®) provides unique, controlled antigen release to improve immune response to vaccination. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Strand KA – PersonEntity: Name: NameFull: D'Angelo H – PersonEntity: Name: NameFull: Olson AM – PersonEntity: Name: NameFull: Walters IR – PersonEntity: Name: NameFull: Snyder EM – PersonEntity: Name: NameFull: Ritter AM – PersonEntity: Name: NameFull: Hite E – PersonEntity: Name: NameFull: Wijesundara YH – PersonEntity: Name: NameFull: Caplan AB – PersonEntity: Name: NameFull: Ivanova DL – PersonEntity: Name: NameFull: Allen I – PersonEntity: Name: NameFull: Han Y – PersonEntity: Name: NameFull: Antunez LR – PersonEntity: Name: NameFull: Dey AK – PersonEntity: Name: NameFull: Steadman BL – PersonEntity: Name: NameFull: Brubaker SW IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 07 Text: 2026 Jul 10 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-4995 Numbering: – Type: volume Value: 395 Titles: – TitleFull: Journal of controlled release : official journal of the Controlled Release Society Type: main |
| ResultId | 1 |